Home / About / Governance / Research Management Committee

Research Management Committee

The Research Management Committee oversees the R&D portfolio and makes recommendations to the Board on funding for grant applications. The Committee guides research directions based on the overall Board-approved strategic plan.

Members of the Committee

Warren is a Professor from the Department of Biological Sciences at the University of Alberta. The Wakarchuk lab investigates the structure and function of the enzymes which make and degrade various glycoconjugates. This work has been enabling the chemo-enzymatic synthesis of bioactive glycoconjugates both in the laboratory and for industrial projects. The Wakarchuk lab has expertise with both mammalian and bacterial carbohydrate active enzymes for glycan remodelling applications.

Dr. DeAngelis’s research has led to commercial applications, including the design of novel hybrid polysaccharide molecules for medical or industrial applications, the formation of biocompatible coatings and surfaces for use in sensors or other implanted devices, the synthesis of defined oligosaccharides that have potential for use as anticancer agents, anticoagulants, or immune system stimulators and the synthesis of sugar-based targeting drug delivery systems. Dr. DeAngelis is a founding scientist of four life science ventures: Hyalose, Heparinex, Choncept and Caisson Biotech.

Dr. Furneaux is one of New Zealand’s most respected scientists. His team includes 33 research scientists whose achievements include 225 publications, 32 reviews and 13 published patent series. Dr. Furneaux, who holds a PhD in Chemistry from Victoria University of Wellington, is a fellow of both the Royal Society of New Zealand and the New Zealand Institute of Chemistry. In 2006 he was awarded the Hector Medal from the Royal Society for his outstanding contribution to the advancement of carbohydrate chemistry and for achieving world-wide recognition of chemistry and pharmacology in New Zealand.

Dr. Kohler is a Professor at the University of Texas Southwestern Medical Center. Research in the Kohler lab focuses on understanding the roles of glycoconjugates in a variety of biological systems.

Professor Nitz’s research program spans the areas of synthetic carbohydrate chemistry and chemical biology. Focusing on bacterial biofilm formation the Nitz lab has efficiently synthesized key carbohydrate adhesin’s that form the structure of the biofilm matrix. These compounds have served as substrates to elucidate the biochemistry and structure of the enzymes required for polysaccharide adhesin synthesis and biofilm formation.

Dr. Plante is Senior Director of Bacterial Immunology at Moderna Therapeutics where he leads the discovery of novel mRNA-based vaccines and antibodies. Previously, Dr. Plante served as Director of Research at Visterra through their acquisition by Otsuka for $430M. At Visterra he led early stage research programs including a CARB-X funded program developing an innovative glycan-targeted antibody-drug conjugate for the treatment of Pseudomonas aeruginosa infections.

Mariela is an immunologist and Professor at the University of Montreal. She is known for research in the areas of infectious diseases and the underlying innate and adaptive immune responses, with a particular focus on the interactions of encapsulated streptococci (such as Streptococcus suis and Group B Streptococcus) with the components of the immune system.

Janice Bailey has been the Scientific Director of the Fonds de recherche du Québec – Nature and Technologies (FRQNT) since 2019. The mandate of the FRQNT is to develop and promote research activities to solve challenges
and stimulate socio-economic development in a manner that will benefit Quebec and other nations. In doing so, the FRQNT prioritizes interdisciplinary international collaboration, research partnerships, and diversity in its approaches.

Observer

Elizabeth is the CEO of GlycoNet. She was involved in the GlycoNet initiative since the Letter of Intent stage and served as the Associate Director, Business for the Alberta Glycomics Centre from 2007–2015. Prior to her position with the Centre, she worked as a manager of large-scale and multi-institutional projects with Genome Prairie. In addition to her PhD in biochemistry, Elizabeth has an MBA in biotechnology management.

Terms of Reference

View Terms of Reference (PDF)

Canadian Glycomics Network
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
Tel: 780-492-6204
Fax: 780-492-4147

Subscribe to GlycoNet’s Newsletter

© CANADIAN GLYCOMICS NETWORK (GLYCONET). ALL RIGHTS RESERVED.

en_USEnglish
Scroll to Top